Cannasat Therapeutics Inc. Reports Results for the Year Ended December 31, 2006

April 26, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TORONTO, ONTARIO -- (MARKET WIRE) -- April 25, 2007 -- Cannasat Therapeutics Inc. (TSX VENTURE: CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the year ended December 31, 2006.

Twitter
LinkedIn
Facebook
Email
Print

Earnings